FDA approves and authorises updated mRNA COVID-19 vaccines
The mRNA COVID-19 vaccines have been updated with a monovalent component that corresponds to the Omicron variant KP.2 strain…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Omicron variant
Sinopharm unit gets OK for clinical trials of mRNA COVID vaccine
The unit, based in the commercial hub of Shanghai, has built a research and development platform, as well as workshops with annual…
Moderna says Omicron booster response stays high through three months
The US has given the go-ahead for booster vaccines that target the currently circulating BA.4 and BA.5 subvariants of Omicron
VINS Bioproducts completes phase-II clinical trials for COVID-19 antidote VINCOV-19
VINCOV-19 is now ready for market authorisation and for simultaneous phase-III clinical trials
Pfizer-BioNTech COVID shot 73.2 per cent effective in kids aged under five years, reveals new data
The updated data released yesterday showed 13 children had COVID-19, at least seven days after receiving a third dose of the…
Bharat Biotech expects regulator’s nod for intranasal COVID-19 vaccine in August
The Drug Controller General of India (DCGI) gave its nod to conduct clinical trials for Bharat Biotech’s intranasal vaccine as…
ICMR study finds Covaxin booster dose improves effectiveness against Delta, Omicron variants
The antibody response, clinical observations, viral load reduction and lung disease severity after virus challenge were observed…
EU approves Evusheld for preventing COVID-19
Evusheld retains neutralising activity against the Omicron BA.2 subvariant
Why we need an Aatmanirbhar booster strategy
An Aatmanirbhar booster strategy will save lives. As a bonus, it will also boost long term development programmes at local…
Third wave of COVID in India likely to peak in early Feb: Study
The researchers at the Indian Institute of Technology Kanpur modelled the daily data of cases from countries such as the US, UK,…